Abundance Wealth Counselors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.05M | Sell |
16,428
-247
| -1% | -$45.8K | 0.57% | 29 |
|
2025
Q1 | $3.48M | Buy |
16,675
+388
| +2% | +$80.9K | 0.73% | 23 |
|
2024
Q4 | $2.89M | Buy |
16,287
+172
| +1% | +$30.6K | 0.63% | 24 |
|
2024
Q3 | $3.18M | Sell |
16,115
-430
| -3% | -$84.9K | 0.66% | 19 |
|
2024
Q2 | $2.84M | Sell |
16,545
-1,285
| -7% | -$220K | 1.31% | 13 |
|
2024
Q1 | $3.25M | Buy |
17,830
+162
| +0.9% | +$29.5K | 0.75% | 20 |
|
2023
Q4 | $2.74M | Buy |
17,668
+250
| +1% | +$38.7K | 0.71% | 22 |
|
2023
Q3 | $2.6M | Sell |
17,418
-350
| -2% | -$52.2K | 0.74% | 19 |
|
2023
Q2 | $2.39M | Sell |
17,768
-1,671
| -9% | -$225K | 1.24% | 13 |
|
2023
Q1 | $3.1M | Sell |
19,439
-1,369
| -7% | -$218K | 0.78% | 16 |
|
2022
Q4 | $3.36M | Buy |
20,808
+910
| +5% | +$147K | 0.92% | 16 |
|
2022
Q3 | $2.67M | Buy |
19,898
+383
| +2% | +$51.4K | 0.76% | 17 |
|
2022
Q2 | $2.99M | Sell |
19,515
-531
| -3% | -$81.3K | 0.81% | 17 |
|
2022
Q1 | $3.25M | Buy |
20,046
+1,325
| +7% | +$215K | 0.88% | 17 |
|
2021
Q4 | $2.54M | Buy |
18,721
+818
| +5% | +$111K | 0.65% | 18 |
|
2021
Q3 | $1.93M | Buy |
17,903
+448
| +3% | +$48.3K | 1.13% | 11 |
|
2021
Q2 | $1.97M | Buy |
17,455
+6,166
| +55% | +$694K | 0.51% | 19 |
|
2021
Q1 | $1.22M | Buy |
11,289
+1,433
| +15% | +$155K | 0.3% | 28 |
|
2020
Q4 | $1.06M | Buy |
9,856
+1,597
| +19% | +$171K | 0.27% | 30 |
|
2020
Q3 | $723K | Buy |
8,259
+1,682
| +26% | +$147K | 0.21% | 45 |
|
2020
Q2 | $646K | Buy |
+6,577
| New | +$646K | 0.2% | 43 |
|